Report : Europe Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Institutes)
Clinical Multimodal Imaging Segment to Dominate Europe Multimodal Image Fusion Software Market during 2021–2028
According to a new market research study on “Europe Multimodal Image Fusion Software Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type and Application” is expected to reach US$ 137.80 million by 2028 from US$ 80.19 million in 2021. The market is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The report provides trends prevailing in the Europe multimodal image fusion software market along with the drivers and restraints pertaining to the market growth. Ascent in numbers of hospital and diagnostics centers is the major factor driving the growth of the Europe multimodal image fusion software market. However, issues associated with the high cost of associated diagnostics equipment hinder the growth of Europe multimodal image fusion software market.
The Europe multimodal image fusion software market is segmented into type, application and country. In terms of type, the multimodal image fusion software market is bifurcated into preclinical multimodal imaging and clinical multimodal imaging. The clinical multimodal imaging segment dominated the market in 2020 and preclinical multimodal imaging segment is expected to be the fastest growing during the forecast period. Based on application, the multimodal image fusion software market is categorized into hospitals, diagnostic centers, and academic and research institutes. The hospitals segment dominated the market in 2020 and diagnostic centers segment is expected to be the fastest growing during the forecast period. Based on country, Europe multimodal image fusion software market is classified into Germany, France, UK, Italy, Russia, and Rest of Europe.
In Europe, the COVID-19 pandemic has a different impact on different countries, as selective countries witnessed an increase in the number of recorded cases and subsequently attracted strict as well as longer lockdown periods or social isolation. However, Western European countries such as Germany, France, Russia, and the UK have seen a comparatively modest decrease in their growth activities because of the strong healthcare systems. To protect their citizens from the virus, the governments have made tremendous investments in backing up their healthcare systems with modern technologies, which has simplified and accelerated COVID-19 diagnosis procedures. Through such investments, European countries also focused on innovative, cost-effective solutions for care giving. According to the European Commission, the rise in the Covid-19 cases across the region has no impact on the number of patients with other diseases such as heart patients, neurological disorder patients, and Alzheimer’s across the region.
Brainlab AG; Bruker Corporation; Carl Zeiss Meditec; FUJIFILM VisualSonics, Inc.; Intrasense SA; Mediso Ltd; MR Solutions Ltd.; and PerkinElmer Inc. are among the leading companies in the Europe multimodal image fusion software market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2018, Bruker Corporation had launched ParaVision 360 preclinical imaging software. It is the most advanced research-grade software for preclinical MRI and had also been extended to nuclear molecular imaging.
Europe Multimodal Image Fusion Software Market, By Country, 2020 and 2028 (%)
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com